Disturbed mitochondrial energy production in methylmalonic aciduria is cell-type and variant-dependent

Inside every cell of the human body, tiny power plants called mitochondria work constantly to generate the energy required for life. These organelles run a complex chemical engine that burns fuel to create electricity, keeping our organs functioning. When this system breaks down, the consequences can be severe, particularly for organs that demand high energy, such as the brain and kidneys. One such breakdown occurs in a rare genetic condition known as methylmalonic aciduria. This disease stems from a missing or broken version of a specific enzyme, a molecular machine named methylmalonyl-CoA mutase. Normally, this enzyme helps process certain fats and proteins, turning them into fuel for the mitochondria. Without it, toxic waste products build up, and the cell's energy supply is threatened. For decades, scientists have suspected that the root of the disease's damage lies in the mitochondria failing to produce enough power, leading to the organ failure and neurological decline seen in patients.

However, the relationship between this missing enzyme and the cell's energy output has remained murky. While previous studies showed that mitochondria in affected tissues looked damaged and stressed, it was unclear if they were actually producing less energy or if the cells were simply struggling to manage the toxic buildup. To solve this puzzle, a team of researchers at the University of Zurich set out to measure the energy production of cells directly, testing different types of cells and different genetic errors to see if the outcome was always the same. They did not rely on guesswork or indirect clues; instead, they placed living cells into a specialized machine that could watch their breathing in real time, measuring exactly how much oxygen they consumed to generate power.

The researchers began by creating a clean slate in the lab. They used gene-editing tools to completely remove the enzyme from human cells grown in a dish, creating a model where the enzyme was entirely absent. They expected these cells to struggle, perhaps showing a clear drop in energy production. Instead, the results were surprising. The cells without the enzyme functioned just as well as healthy cells. They burned fuel, consumed oxygen, and generated energy at normal levels. The researchers repeated this test with skin cells taken from actual patients who had the same complete absence of the enzyme, and the result held true: the cells were not energy-deprived. This finding challenged the long-held assumption that the mere absence of the enzyme automatically cripples the cell's power plant.

The story changed when the researchers looked at a different kind of genetic error. Instead of removing the enzyme entirely, they introduced specific mistakes in the DNA that altered the shape of the enzyme but did not destroy it completely. These are known as missense variants, where the protein is still made but is slightly malformed. The team focused on a specific variant, p.N219Y, which is common in patients and known to cause severe disease. When they engineered cells to carry this specific variant, the outcome was starkly different. These cells did show a significant drop in energy production. Their power plants were less efficient, struggling to generate the same amount of energy as healthy cells, even though they still contained the enzyme. This suggested that the problem was not simply the lack of the enzyme, but rather the specific way a malformed enzyme behaves inside the cell.

To understand why this difference existed, the researchers tested how the cells responded when their fuel supply was changed. In the body, cells can switch between different types of fuel, such as sugar or fats, to keep the energy engine running. The team removed these standard fuels one by one and replaced them with alternatives, forcing the cells to rely on a single source. Under these stressful conditions, the cells with the completely missing enzyme adapted well, finding a way to maintain their energy levels. In contrast, the cells with the malformed p.N219Y variant faltered. When the fuel source was restricted, their energy production dropped dramatically. This indicated that the malformed enzyme made the cells fragile, unable to cope with changes in their environment, whereas cells with no enzyme at all were surprisingly robust.

The investigation then moved to cells that more closely resemble the tissues most damaged in patients: kidney cells and nerve cells. The researchers examined urine-derived kidney cells from patients and found that, just as in the lab models, these cells had reduced energy production. This confirmed that the defect seen in the dish was real and relevant to the human body. However, when they turned to nerve cells, grown from stem cells derived from patients, the picture became more complex. Even with the same harmful genetic variant, these developing nerve cells did not show the same drop in energy production. This highlighted a crucial point: the impact of the disease depends heavily on the type of cell involved. A defect that cripples a kidney cell might not affect a nerve cell in the same way, suggesting that the body's tissues have different ways of coping with the same genetic error.

The study concludes that the damage caused by this metabolic disease is not a simple case of "no enzyme equals no energy." Instead, the effect is highly specific, depending on both the exact genetic mutation and the type of cell being studied. A complete absence of the enzyme does not necessarily stop the cell from making energy, but a specific, malformed version of the enzyme can severely disrupt the process, especially when the cell is under stress. This nuance explains why the disease affects some organs more than others and why patients with different genetic mutations can have varying symptoms. By mapping out exactly how different cells react to different errors, the researchers have provided a clearer map of the disease, showing that the path to understanding and treating it requires looking at the specific details of the genetic mistake and the unique needs of each cell type.